TrialDiabetologia2026

Impact of canagliflozin on the cardiorenal effects of dietary sodium intake in type 2 diabetes: a post hoc analysis of the CREDENCE trial.

Martina Chiriacò et al.PubMed ↗Publisher ↗

No numbers read from the abstract.